INSM - Insmed Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
245,358
245,358
188,461
164,413
136,467
Cost of Revenue
55,126
55,126
44,152
39,872
24,212
Gross Profit
190,232
190,232
144,309
124,541
112,255
Operating Expenses
Research Development
397,518
397,518
272,744
181,157
131,711
Selling General and Administrative
244,982
265,784
234,273
203,613
210,796
Total Operating Expenses
647,553
668,355
512,069
389,773
347,500
Operating Income or Loss
-457,321
-478,123
-367,760
-265,232
-235,245
Interest Expense
22,455
26,446
40,473
29,564
27,705
Total Other Income/Expenses Net
3,616
24,418
-28,179
2,108
9,390
Income Before Tax
-480,151
-480,151
-436,412
-292,688
-253,560
Income Tax Expense
1,383
1,383
-1,758
1,402
777
Income from Continuing Operations
-481,534
-481,534
-434,654
-294,090
-254,337
Net Income
-481,534
-481,534
-434,654
-294,090
-254,337
Net Income available to common shareholders
-481,534
-481,534
-434,654
-294,090
-254,337
Basic EPS
-
-3.91
-3.88
-3.01
-3.01
Diluted EPS
-
-3.91
-3.88
-3.01
-3.01
Basic Average Shares
-
123,035
112,111
97,605
84,560
Diluted Average Shares
-
123,035
112,111
97,605
84,560
EBITDA
-
-448,652
-390,887
-258,121
-220,862